Biological bypass shows promise in coronary artery disease

A new gene therapy that targets the heart and requires only one treatment session has been found safe for patients with coronary artery disease, according to a successful trial carried out in Finland.

Be the first to comment

Leave a Reply

Your email address will not be published.


*